Dental Treatment Information

2019 Archives

	Cuba advances HIV/AIDS vaccine project CGTN \| December 21, 2019
	Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States Journal of the International AIDS Society \| December 20, 2019
	How Close Are We to Curing HIV? IDSE.net \| December 13, 2019
	Unsung heroes: Pittsburgh men, decades-long study impact HIV/AIDS research TribLIVE \| December 15, 2019
	Vesicles released by bacteria may reduce the spread of HIV in human tissue NIH \| December 11, 2019
	Gay, bisexual men increasingly agree: HIV “Undetectable Equals Untransmittable” NIH \| December 5, 2019
	Preventive HIV vaccine Enters Phase 3 Global Study IAS 2019: Conference on HIV Pathogenesis Treatment and Prevention Mexico City July 21-24 2019
	The Future—And the End?—of AIDS Columbia University Irving Medical Center \| November 27, 2019
	ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention ViiV \| November 21, 2019
	Colonic microbiota exhibits disparate associations with HIV infection and sexual practices 21st International Workshop n Co-morbidities and Adverse Drug Reactions in HIV
	Only 1% HIV Diagnosis Rate More Than 6 Months After PEP in 975 People 17th European AIDS Conference, November 6-9, 2019, Basel
	Maryland Medical Company Claims To Have Cure For HIV, AIDS CBS Pittsburgh \| November 8, 2019
	First New HIV Strain in 19 Years Identified Scientific American \| November 6, 2019
	Researchers adapt CAR-T immunotherapy to target the HIV latent reservoir Medical Xpress \| October 24, 2019
	NIH Launches New Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global Scale HIV.gov \| October 24, 2019
	The Future of ARV-Based Prevention and More AVAC.org \| October 23, 2019
	NIH launches new collaboration to develop gene-based cures for sickle cell disease and HIV on global scale NIH \| October 23, 2019
	Drug reverses signs of liver disease in people living with HIV NIH \| October 15, 2019
	The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0175
	Study demonstrates antibody responses within 6 weeks of initial vaccination EurekAlert \| October 1, 2019
	AIDS Treatment: Russian Researchers Create New Medications QS WOW News \| September 29, 2019
	UAB researchers land funding to combat HIV Birmingham Business Journal \| September 27, 2019
	UC San Diego Researchers Isolate Switch that Kills Inactive HIV UC San Diego Health \| September 24, 2019
	Papillomaviruses May Be Able To Be Spread By Blood EurekAlert \| September 11, 2019
	CRISPR shown to be safe to target HIV (but unsuccessful so far) The Daily Briefing \| September 13, 2019
	An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals Science Translational Medicine \| September 7, 2019
	The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment The Lancet \| September 2019
	Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities The Lancet \| September 2019
	Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2018 Jan 6;66(2):213-219. doi: 10.1093/cid/cix755.
	Cellular therapies are the next big step in fight against HIV/Aids Independent Online \| August 31, 2019
	Animal activists are on the wrong side of the fight against AIDS STAT \| August 30, 2019
	Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection BusinessWire \| August 28, 2019
	Repeated semen exposure promotes host resistance to infection in preclinical HIV model EurekAlert \| August 21, 2019
	New Molecule Identified That May Further Suppress Effectively Treated HIV POZ \| August 14, 2019
	Cancer therapy returns to original target: HIV Science Magazine \| August 9, 2019
	HOPE trial: Dapivirine vaginal ring reduces HIV risk by estimated 39% Healio \| August 6, 2019
	Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV JCI \| July 22, 2019
	Johnson & Johnson Announces New Public-Private Partnership to Support First Phase 3 Efficacy Study of Janssen’s Investigational Prophylactic HIV Vaccine IAS 2019: Conference on HIV Pathogenesis Treatment and Prevention, Mexico City, July 21-24 2019
	PrEP use high but wanes after three months among young African women NIH \| July 23, 2019
	Developing a novel HIV vaccine: DNA and recombinant proteins Science Daily \| July 23, 2019
	Duke Human Vaccine Institute receives $129 million grant for HIV/AIDS research Duke Chronicle \| July 19, 2019
	HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa New England Journal of Medicine \| July 18, 2019
	Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART) New England Journal of Medicine \| July 18, 2019
	Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana New England Journal of Medicine \| July 18, 2019
	HIV-1 Epidemic Control — Insights from Test-and-Treat Trials, Slim Abdool Karim New England Journal of Medicine \| July 18, 2019

	Acceptability and Preferences for Long-Acting Antiretroviral Formulations Among People Living with HIV infection IAPAC Adherence June 17-19 Miami
	Enlisting CRISPR in the Quest for an HIV Cure NIH \| July 16th, 2019
	Johnson & Johnson to start testing on new type of HIV vaccine in US and Europe New York Daily News \| July 13, 2019
	Consortium Led by Scripps Research Gets $129 Million for HIV/AIDS Vaccine Clinical Trials Times of San Diego \| July 10, 2019
	HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.
	HIV eliminated from the genomes of living animals Nature Communications \| June 2019
	Genotype Testing at HIV Diagnosis Provides No Benefit Infectious Disease Advisor \| June 24, 2019
	Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection Science Translational Medicine \| June 15, 2019
	AIDSinfo Updates Investigational HIV Drug Fact Sheets AIDSinfo \| June 14, 2019
	Women and Clinical Trials The New York Times \| June 14, 2019
	GSK partners with CRISPR pioneer Doudna to search for new drugs STAT News \| June 13, 2019
	Durable Control of HIV Infection in the Absence of Antiretroviral Therapy - Opportunities and Obstacles Viewpoint \| June 6, 2019
	Trump administration imposes new restrictions on fetal tissue research Washington Post \| June 5, 2019
	Statement from the Department of Health and Human Services HHS.gov \| June 5, 2019
	Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study JAMA Oncol. Published online June 2, 2019
	HIV Vaccine Awareness Day 2019 — May 18, 2019 National Institutes of Health \| May 17, 2019
	Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from ... Yahoo Finance \| May 13, 2019
	NIH Trial Evaluates Long-acting HIV Medication Unable to Adhere to Strict Daily Regimens - LATITUDE study compares monthly injectable antiretroviral therapy to daily oral drugs NIH \| May 9, 2019
	NIH awards will advance development of vaccines for sexually transmitted infections NIH \| May 5, 2019
	Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base Cancer. 2019 May 3. doi: 10.1002/cncr.32158
	Boston hospital receives largest philanthropic gift in history for HIV/AIDS vaccine research WCVB Boston \| April 25, 2019
	Novel antibody may suppress HIV for up to four months NIH \| April 17, 2019
	Scientists find another way HIV can hide from vaccines Yale News \| April 10, 2019
	Orion Biotechnology to Present OB-002 in Vitro Potency Data at the 10th International AIDS Society HIV Science Meeting in Mexico City in July 2019 PR Newswire \| March 28, 2019
	Aaron Diamond AIDS Research Center to Join Columbia University Columbia University \| March 20, 2019
	Curing HIV just got more complicated. Can CRISPR help? Science Magazine \| March 15, 2019
	Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach PLoS Med. 2019 Mar 4;16(3):e1002756. doi: 10.1371/journal.pmed.1002756. eCollection 2019 Mar.
	This is Not A Cure for My H.I.V. New York Times \| March 9, 2019
	One step closer to ultra-long-acting PREP? AIDS: march 2019
	New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration NATAP \| February 20th, 2019
	Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate
	HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge Nat Commun. 2019 Feb 18;10(1):798. doi: 10.1038/s41467-019-08739-4
	NIH Clinical Trial to Track Outcomes of Liver Transplantation from HIV-Positive Donors to HIV-Positive Recipients HIV.gov \| February 15, 2019
	Ending the HIV Epidemic: A Plan for the United States NIH \| February 7, 2019
	Study of PrEP and vaginal ring for HIV prevention begins in girls and young women NIH \| February 7, 2019
	HIV-AIDS drug could help treat Alzheimer's and other age-related diseases, Brown researchers say The Providence Journal \| February 6, 2019
	Hodgkin's lymphoma and its association with EBV and HIV infection Crit Rev Clin Lab Sci. 2018 Mar;55(2):102-114. doi: 10.1080/10408363.2017.1422692. Epub 2018 Jan 9
	Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer A Systematic Review
	Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.
	Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort PLoS One. 2019 Jan 16;14(1):e0210398. doi: 10.1371/journal.pone.0210398. eCollection 2019
	Incidence and Correlates of STIs among Black Men who have Sex with Men Participating in the HPTN 073 PrEP Study. Clin Infect Dis. 2019 Jan 7. doi: 10.1093/cid/ciy1141.
	Scientists achieve the first proof of concept for an HIV broadly-neutralising antibody vaccine in ... aidsmap \| January 2, 2019

HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya

Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base

Orion Biotechnology to Present OB-002 in Vitro Potency Data at the 10th International AIDS Society HIV Science Meeting in Mexico City in July 2019

New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge

Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort